continuum of progress

Seqens is an integrated global leader in pharmaceutical synthesis and specialty ingredients, delivering outstanding performance, unrivalled market responsiveness and custom-made solutions to our customers.

A GLOBAL PLAYER IN PHARMACEUTICAL SYNTHESIS AND SPECIALTY INGREDIENTS

Two main business activities supported by a broad range of cross-functional technologies, R&D expertise and global assets.

STRONG R&D CAPABILITIES TO DEVELOP DISTINCTIVE, CUSTOM-MADE SOLUTIONS, TO SPEED UP OUR CLIENTS’ PROJECTS BY ADDING VALUE.

  • 3 state-of-the-art R&D centers in Europe and the U.S.
  • Seqens unique range of technologies enables us to manufacture complex molecules for small- and large-scale demands

Our services

  • Custom research & innovation
  • Custom development
  • Custom manufacturing
  • Specialty generic
  • Essential APIs & intermediates
  • Advanced specialties

Seqens group

SEQENS key figures

0
employees
0
scientists, engineers and other experts
0
manufacturing sites
0
R&D centers in the EU and US